Table 2.
Variable | Total sample (n = 108) | Adherent group (n = 98) | Non-adherent group (n = 10) | p value |
---|---|---|---|---|
Methotrexate | 76 (70%) | 70 (71%) | 6 (60%) | 0.34 |
Prednisone | 41 (38%) | 36 (37%) | 5 (50%) | 0.50 |
Hydroxychloroquine | 31 (29%) | 29 (30%) | 2 (20%) | |
Sulfasalazine | 16 (15%) | 13 (13%) | 4 (40%) | |
Etanercept | 12 (11%) | 9 (9%) | 3 (30%) | |
Adalimumab | 11 (10%) | 10 (10%) | 1 (10%) | |
Abatacept | 6 (6%) | 5 (5%) | 1 (10%) | |
Infliximab | 5 (5%) | 5 (5%) | 0 | |
Leflunomide | 4 (4%) | 4 (4%) | 0 | |
Rituximab | 1 (1%) | 1 (1%) | 0 | |
Cytoxan | 1 (1%) | 1 (1%) | 0 |
Proportions if adherent and nonadherent groups were compared with Chi square analyses.
Chi square analyses were not performed when there were less than 5 cases per cell.
Totals may be equal 100% due to rounding.